Sector-specific insights for the Life Sciences sector
R&D TAX RELIEF AND CLINICAL TRIALS: WHAT THERAPEUTIC COMPANIES CAN (AND CAN’T) CLAIM IN THE UK
For therapeutic companies, clinical trials are often the largest and most complex component of R&D expenditure. Yet they are also one [...]